Published in J Virol on May 01, 1989
RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem (2001) 9.66
A specific base transition occurs on replicating hepatitis delta virus RNA. J Virol (1990) 4.05
Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol (1990) 3.57
The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc Natl Acad Sci U S A (1991) 3.52
Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J Virol (1995) 2.54
Assembly of hepatitis delta virus particles. J Virol (1992) 2.36
A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci U S A (1993) 2.25
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
Substrate recognition by ADAR1 and ADAR2. RNA (2001) 2.09
Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen. J Virol (1990) 2.03
Expression of hepatitis delta virus RNA deletions: cis and trans requirements for self-cleavage, ligation, and RNA packaging. J Virol (1994) 1.93
Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism. Proc Natl Acad Sci U S A (1992) 1.87
Relating structure to function in the hepatitis delta virus antigen. J Virol (1993) 1.82
In vitro-synthesized hepatitis delta virus RNA initiates genome replication in cultured cells. J Virol (1990) 1.79
trans-dominant inhibition of human hepatitis delta virus genome replication. J Virol (1991) 1.79
Cloned hepatitis delta virus cDNA is infectious in the chimpanzee. J Virol (1989) 1.75
Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J Virol (1991) 1.74
The antigen of hepatitis delta virus: examination of in vitro RNA-binding specificity. J Virol (1991) 1.70
Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles. J Virol (1991) 1.67
Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion. J Virol (1993) 1.65
The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates. J Virol (1993) 1.62
RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. J Virol (1993) 1.57
Ribonucleoprotein complexes of hepatitis delta virus. J Virol (1993) 1.56
Hepatitis delta virus RNA editing is highly specific for the amber/W site and is suppressed by hepatitis delta antigen. Mol Cell Biol (1998) 1.53
A new Ebola virus nonstructural glycoprotein expressed through RNA editing. J Virol (2011) 1.53
Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication. J Virol (1998) 1.51
Editing on the genomic RNA of human hepatitis delta virus. J Virol (1992) 1.48
Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens. J Virol (1992) 1.45
Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2. J Virol (2001) 1.38
RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol (2000) 1.36
Specific HDV RNA-templated transcription by pol II in vitro. RNA (2000) 1.36
Replication of hepatitis delta virus RNA: effect of mutations of the autocatalytic cleavage sites. J Virol (1993) 1.34
Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J Virol (2007) 1.33
Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR. J Clin Microbiol (2004) 1.33
In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J Clin Invest (2003) 1.33
Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen. J Virol (1992) 1.32
Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA. J Virol (2002) 1.29
Rolling circle replication of hepatitis delta virus RNA is carried out by two different cellular RNA polymerases. J Virol (2002) 1.28
Identification and characterization of a hepatitis delta virus RNA transcriptional promoter. J Virol (1996) 1.27
Nucleotide sequence stability of the genome of hepatitis delta virus. J Virol (1995) 1.27
Immunogenic domains of hepatitis delta virus antigen: peptide mapping of epitopes recognized by human and woodchuck antibodies. J Virol (1990) 1.25
Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition. J Virol (2005) 1.25
Replication of the human hepatitis delta virus genome Is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences. J Virol (2001) 1.25
Functional study of hepatitis delta virus large antigen in packaging and replication inhibition: role of the amino-terminal leucine zipper. J Virol (1992) 1.25
Effects of nucleotide changes on the ability of hepatitis delta virus to transcribe, process, and accumulate unit-length, circular RNA. J Virol (1997) 1.24
Host RNA polymerase requirements for transcription of the human hepatitis delta virus genome. J Virol (2001) 1.21
Redistribution of the delta antigens in cells replicating the genome of hepatitis delta virus. J Virol (1996) 1.21
Tissue culture system for infection with human hepatitis delta virus. J Virol (1991) 1.21
Functional motifs of delta antigen essential for RNA binding and replication of hepatitis delta virus. J Virol (1993) 1.21
RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus. J Virol (2005) 1.21
Circular single-stranded RNA replicon in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1990) 1.21
Genotype-specific complementation of hepatitis delta virus RNA replication by hepatitis delta antigen. J Virol (1998) 1.20
Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes. Proc Natl Acad Sci U S A (2013) 1.19
Regulation of polyadenylation of hepatitis delta virus antigenomic RNA. J Virol (1991) 1.16
Immune response to synthetic peptides of hepatitis delta antigen. J Clin Microbiol (1993) 1.16
In vivo RNA-directed transcription, with template switching, by a mammalian RNA polymerase. EMBO J (2002) 1.16
Introduction of hepatitis delta virus into animal cell lines via cationic liposomes. J Virol (1994) 1.15
Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen. J Virol (1993) 1.15
Experimental transmission of human hepatitis delta virus to the laboratory mouse. J Virol (1993) 1.15
A prenylation inhibitor prevents production of infectious hepatitis delta virus particles. J Virol (2002) 1.13
Mutations in the carboxyl-terminal domain of the small hepatitis B virus envelope protein impair the assembly of hepatitis delta virus particles. J Virol (1999) 1.12
Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA. J Virol (1998) 1.12
Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing. J Virol (2002) 1.10
Origin of hepatitis delta virus mRNA. J Virol (2000) 1.10
Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes. J Virol (2004) 1.10
Characterization of the 5' ends for polyadenylated RNAs synthesized during the replication of hepatitis delta virus. J Virol (1999) 1.10
RNA editing in hepatitis delta virus genotype III requires a branched double-hairpin RNA structure. J Virol (2002) 1.09
Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNA in vivo. J Virol (1996) 1.09
Continuous expression and replication of the hepatitis delta virus genome in Hep G2 hepatoblastoma cells transfected with cloned viral DNA. Proc Natl Acad Sci U S A (1990) 1.09
Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. J Virol (2004) 1.08
Nuclear localization signals, but not putative leucine zipper motifs, are essential for nuclear transport of hepatitis delta antigen. J Virol (1992) 1.07
The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication. J Virol (2000) 1.07
Initiation of hepatitis delta virus genome replication. J Virol (1998) 1.06
The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent. J Virol (2009) 1.05
Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J Virol (2006) 1.05
Hepatitis delta virus mutant: effect on RNA editing. J Virol (1995) 1.05
Self-association of a synthetic peptide from the N terminus of the hepatitis delta virus protein into an immunoreactive alpha-helical multimer. Proc Natl Acad Sci U S A (1995) 1.05
Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10. J Virol (2000) 1.04
Assembly of hepatitis delta virus: particle characterization, including the ability to infect primary human hepatocytes. J Virol (2007) 1.04
Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen. J Virol (1994) 1.03
Hepatitis delta virus ribonucleoproteins shuttle between the nucleus and the cytoplasm. RNA (2002) 1.02
Susceptibility of human hepatitis delta virus RNAs to small interfering RNA action. J Virol (2003) 1.02
Localization of hepatitis delta virus RNA in the nucleus of human cells. RNA (1998) 1.02
The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus. J Virol (1994) 1.01
Mutational analysis of delta antigen: effect on assembly and replication of hepatitis delta virus. J Virol (1994) 1.01
By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression. J Virol (2004) 1.00
Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established. J Virol (2002) 0.99
Transgenic mice support replication of hepatitis delta virus RNA in multiple tissues, particularly in skeletal muscle. J Virol (1995) 0.99
Expression of the hepatitis delta virus large and small antigens in transgenic mice. J Virol (1994) 0.99
Interactions between hepatitis delta virus proteins. J Virol (2000) 0.98
A tryptophan-rich motif in the carboxyl terminus of the small envelope protein of hepatitis B virus is central to the assembly of hepatitis delta virus particles. J Virol (2006) 0.96
Characterization of the phosphorylated forms and the phosphorylated residues of hepatitis delta virus delta antigens. J Virol (1999) 0.96
Packaging of hepatitis delta virus RNA via the RNA-binding domain of hepatitis delta antigens: different roles for the small and large delta antigens. J Virol (1994) 0.95
Functional domains of delta antigens and viral RNA required for RNA packaging of hepatitis delta virus. J Virol (1995) 0.95
Large hepatitis delta antigen in packaging and replication inhibition: role of the carboxyl-terminal 19 amino acids and amino-terminal sequences. J Virol (1995) 0.95
Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev (1993) 0.94
The role of a metastable RNA secondary structure in hepatitis delta virus genotype III RNA editing. RNA (2006) 0.94
Large hepatitis delta antigen is a novel clathrin adaptor-like protein. J Virol (2007) 0.93
The conserved serine 177 in the delta antigen of hepatitis delta virus is one putative phosphorylation site and is required for efficient viral RNA replication. J Virol (2001) 0.93
Limitations to replication of hepatitis delta virus in avian cells. J Virol (2000) 0.92
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci U S A (1977) 41.76
SV40-transformed simian cells support the replication of early SV40 mutants. Cell (1981) 34.67
Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol (1987) 12.66
Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res (1982) 11.72
Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant Biol (1986) 11.66
Preparation of a semipermanent mounting medium for fluorescent antibody studies. Virology (1960) 7.59
Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature (1986) 7.38
Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A (1986) 5.23
delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A (1980) 5.12
Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol (1988) 4.96
Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen. Proc Natl Acad Sci U S A (1986) 4.73
Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci U S A (1987) 4.72
Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol (1988) 4.59
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J Virol (1988) 4.05
Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol (1986) 3.63
Dynamics of membrane-skeleton (fodrin) organization during development of polarity in Madin-Darby canine kidney epithelial cells. J Cell Biol (1986) 3.24
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
Antigens of hepatitis delta virus in the liver and serum of humans and animals. J Infect Dis (1986) 3.08
Duck hepatitis B virus (DHBV) particles produced by transient expression of DHBV DNA in a human hepatoma cell line are infectious in vitro. J Virol (1988) 3.03
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. J Virol (1988) 2.99
Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A (1984) 2.87
Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun (1984) 2.81
Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes. J Virol (1987) 2.36
Homologous recombination of SV40 DNA in COS7 cells occurs with high frequency in a gene dose independent fashion. Nucleic Acids Res (1988) 1.17
delta Antigen in hepatitis B: immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV infection. Hepatology (1981) 1.12
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging (1999) 13.26
Behavioral disinhibition and the development of substance-use disorders: findings from the Minnesota Twin Family Study. Dev Psychopathol (1999) 5.90
Diagnosis and management of aortic dissection. Eur Heart J (2001) 5.39
Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A (1986) 5.23
Differences in human alpha- and beta-globin gene expression in mouse erythroleukemia cells: the role of intragenic sequences. Cell (1984) 5.12
An investigation of traveller's diarrhoea. Lancet (1970) 4.99
Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol (1988) 4.96
TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem (1997) 4.61
Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol (1988) 4.59
A specific base transition occurs on replicating hepatitis delta virus RNA. J Virol (1990) 4.05
Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus. J Virol (1988) 4.05
Expression and structure of the human NGF receptor. Cell (1986) 3.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med (1994) 3.72
Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol (1990) 3.57
Inhibition of interferon action by actinomycin. Biochem Biophys Res Commun (1964) 3.55
NYVAC: a highly attenuated strain of vaccinia virus. Virology (1992) 3.38
A study of Escherichia coli isolated from chronic urinary infection. J Med Microbiol (1969) 3.32
Template switching by reverse transcriptase during DNA synthesis. J Virol (1990) 2.98
Using nurses for preventive activities with computer assisted follow up: a randomised controlled trial. BMJ (1989) 2.95
Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study. Lancet (1977) 2.90
Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res (2001) 2.90
Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation (2009) 2.85
Immunization against Diphtheria with Alum-precipitated Toxoid-II. Br Med J (1942) 2.77
Psychotic illness following 'mabi bark tea' consumption. Br J Psychiatry (1992) 2.72
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J (2004) 2.63
Comparison of influenza serological techniques by international collaborative study. Vaccine (1994) 2.55
Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci U S A (1997) 2.54
MutS mediates heteroduplex loop formation by a translocation mechanism. EMBO J (1997) 2.52
A homeodomain protein related to caudal regulates intestine-specific gene transcription. Mol Cell Biol (1994) 2.42
Transient Induction of Phenylalanine Ammonia-Lyase and 4-Coumarate: CoA Ligase mRNAs in Potato Leaves Infected with Virulent or Avirulent Races of Phytophthora infestans. Plant Physiol (1987) 2.36
Replication of human hepatitis delta virus in primary cultures of woodchuck hepatocytes. J Virol (1987) 2.36
Assembly of hepatitis delta virus particles. J Virol (1992) 2.36
Structural asymmetries in the human brain: a voxel-based statistical analysis of 142 MRI scans. Cereb Cortex (2001) 2.32
A constitutive promoter directs expression of the nerve growth factor receptor gene. Mol Cell Biol (1988) 2.26
Immunisation with canarypox virus expressing rabies glycoprotein. Lancet (1992) 2.09
Rapid immune response to influenza vaccination. Lancet (1993) 2.09
Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology (1998) 2.05
Phylogenetic aspects of C-reactive protein and related proteins. Ann N Y Acad Sci (1982) 2.03
Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen. J Virol (1990) 2.03
Hereditary haemorrhagic telangiectasia, an Australian cohort: clinical and investigative features. Intern Med J (2014) 1.98
Reverse transcriptase of human immunodeficiency virus type 1: functionality of subunits of the heterodimer in DNA synthesis. J Virol (1992) 1.94
Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans R Soc Trop Med Hyg (1998) 1.91
The nerve growth factor receptor gene is at human chromosome region 17q12-17q22, distal to the chromosome 17 breakpoint in acute leukemias. Proc Natl Acad Sci U S A (1986) 1.91
Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther (1992) 1.88
An internal deletion in the cytoplasmic tail reverses the apical localization of human NGF receptor in transfected MDCK cells. J Cell Biol (1991) 1.87
The stability and properties of bimolecular lipid leaflets in aqueous solutions. J Theor Biol (1963) 1.80
Self-ligating RNA sequences on the antigenome of human hepatitis delta virus. J Virol (1989) 1.78
Ketamine sedation for children in the emergency department. Emerg Med (Fremantle) (2001) 1.78
Cloned hepatitis delta virus cDNA is infectious in the chimpanzee. J Virol (1989) 1.75
Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators. Eur J Heart Fail (1999) 1.75
A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. Am J Obstet Gynecol (2001) 1.73
Outbreak of infantile gastro-enteritis caused by Escherichia coli O114. Arch Dis Child (1970) 1.71
The antigen of hepatitis delta virus: examination of in vitro RNA-binding specificity. J Virol (1991) 1.70
Isolation and characterization of C-reactive protein and serum amyloid P component in the rat. Immunology (1982) 1.67
Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine (1991) 1.66
Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study. Neurology (2010) 1.66
Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Crit Care Med (1999) 1.65
Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur J Vasc Endovasc Surg (1996) 1.65
Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J Clin Oncol (2001) 1.64
Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques. Neurology (1999) 1.64
Controlling deaths from volatile substance abuse in under 18s: the effects of legislation. BMJ (1992) 1.63
The variation of capacitance and conductance of bimolecular lipid membranes with area. J Theor Biol (1965) 1.62
The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates. J Virol (1993) 1.62
Acute lobar atelectasis. A comparison of two chest physiotherapy regimens. Chest (1990) 1.59
Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol (1999) 1.59
Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol (1999) 1.58
Long-term outcome of episodes of major depression. Clinical and public health significance. JAMA (1984) 1.58
Avoided and avoidable risks of cancer. Carcinogenesis (1997) 1.58
Negative regulation of the serine/threonine kinase B-Raf by Akt. J Biol Chem (2000) 1.58
Modifications of testosterone-dependent behaviors by estrogen receptor-alpha gene disruption in male mice. Endocrinology (1998) 1.57
Polar group orientation and the electrical properties of lecithin bimolecular leaflets. J Theor Biol (1965) 1.57
RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. J Virol (1993) 1.57
Combined Active and Passive Immunization against Diphtheria: II. Control of Epidemics in the Field. Br Med J (1941) 1.57
Ribonucleoprotein complexes of hepatitis delta virus. J Virol (1993) 1.56
Specificities involved in the initiation of retroviral plus-strand DNA. J Virol (1990) 1.55
Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group. Epilepsia (1996) 1.54
Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis (1991) 1.53
The influence of lipid composition and of some adsorbed proteins on the capacitance of black hydrocarbon membranes. J Theor Biol (1965) 1.51
Spin waves and revised crystal structure of honeycomb iridate Na2IrO3. Phys Rev Lett (2012) 1.49
Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum (1984) 1.49
Editing on the genomic RNA of human hepatitis delta virus. J Virol (1992) 1.48
A cluster randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of classroom-based cognitive-behavioural therapy (CBT) in reducing symptoms of depression in high-risk adolescents. Health Technol Assess (2013) 1.46
Canal adaptation and coronal leakage: lateral condensation compared to Thermafil. J Am Dent Assoc (1995) 1.45
Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol (2000) 1.45
Bier's block--the experience of Australian emergency departments. Med J Aust (1994) 1.44
Reprinted article "Factors associated with early failure of arteriovenous fistulae for haemodialysis access". Eur J Vasc Endovasc Surg (2011) 1.44
Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem (1997) 1.42
Trace element concentrations in patients on home enteral feeding: two cases of severe copper deficiency. Ann Clin Biochem (2005) 1.41
Wilfred Trotter: Presidential Address given at the meeting of the Surgical Section of The Royal Society of Medicine on 3rd November, 1948. Ann R Coll Surg Engl (1949) 1.41
Circumstances of sexual and physical victimization of black psychiatric outpatients. J Natl Med Assoc (1989) 1.41
BCL-X expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res (1998) 1.41
Personality testing in 226 patients with urinary incontinence. Br J Urol (1986) 1.41
The genetic heterogeneity of lactic acidosis: occurrence of recognizable inborn errors of metabolism in pediatric population with lactic acidosis. Pediatr Res (1980) 1.41